scientific program • symposia - American Society for Reproductive ...

44 TH ANNUAL POSTGRADUATE PROGRAM
Developed in Cooperation with the Society for Reproductive Endocrinology and Infertility, the PCOS Society, and the Androgen Excess Special Interest Group
FACULTY
Enrico Carmina, M.D., Chair
Daniel A. Dumesic, M.D.
Terhi Piltonen, M.D., Ph.D.
Elisabet Stener-Victorin, Ph.D.
ACGME COMPETENCY
Patient Care
NEEDS ASSESSMENT AND COURSE DESCRIPTION
Polycystic ovary syndrome (PCOS) is one of the most common endocrinologic conditions, affecting 6-8% of women. There is
a lack of understanding about the early onset of the condition, as well as confusion over the best management strategies,
the genetic nature of the disease and the possible familial impact of PCOS. This results in lack of appropriate advice in the
office setting to all possible affected members of the family.
This course, aimed at clinicians and laboratory scientists alike, will provide the latest information on what is known about
the development of PCOS and the different concerns across the lifespan, from preadolescence to postmenopause.
Evidence-based treatment protocols regarding physical exercise, acupuncture, oral contraceptive and statin therapy will
be reviewed to provide up-to-date recommendations for patient care.
LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:
1. Describe the important features of the diagnosis of PCOS and its presentation and impact of phenotypes on
cardiovascular disease risk.
2. Summarize the impact of environment, nutrition and obesity on the development and severity of PCOS.
3. Define effective treatment strategies for non-fertility care.
________________________________________________________________________________________________________________________
Developed in Cooperation with the European Society for Human Reproduction and Embryology
FACULTY
Mary Stephenson, M.D., Chair
Ole B. Christiansen, M.D., Ph.D., Chair
Kurt T. Barnhart, M.D., M.S.C.E.
Roy G. Farquharson, M.D.
Mariette Goddijn, M.D., Ph.D.
William H. Kutteh, M.D., Ph.D., H.C.L.D.
ACGME COMPETENCY
Patient Care
PCOS: METABOLIC IMPACT AND LONG-TERM MANAGEMENT
Course PG6 (Saturday) • ROOM 224 G/H CME
EARLY PREGNANCY WORKSHOP
Course PG7 (Saturday) • ROOM 224 E/F CME
NEEDS ASSESSMENT AND COURSE DESCRIPTION
There are many unclear and controversial issues surrounding early pregnancy. First, the location and management of
symptomatic early pregnancy remains a challenge to the clinician. Second, new guidelines recommend new, less negative
terminology, for example, replacing “abortion” with “miscarriage”, both in clinical practice and in textbooks and scientific
journals, but such changes are not universally used and further discussion ensues. Third, chromosome testing of couples
with a history of recurrent miscarriage has been universally accepted as standard of care but recent studies raise doubts
about its cost effectiveness. Fourth, management of idiopathic recurrent miscarriage remains controversial, although recent
randomized controlled trials suggest that empiric use of aspirin and/or heparin does not improve pregnancy outcome.
This presentation, designed for primary care physicians, physicians specializing in fertility, genetics, obstetrics and
gynecology and internal medice, nurses and genetic counselors, will review the most up-to-date guidelines and
perspectives from experts in the field from both North America and Europe. Discussions regarding the management of early
pregnancy will be based on the highest level of evidence in the literature. Topics to be addressed include early pregnancy
terminology, debates over treatment of thrombophilias in pregnancy and chromosome testing of miscarriages, and future
directions in the field.
45